pe
pep-10335 v1 CC-BY-SA-4.0

Lab peptide that targets brain galanin receptors (CHEMBL578710)

A short experimental peptide built to latch onto galanin receptors, proteins in the brain and nerves involved in mood, appetite, and pain signaling. Not a medicine; used only as a research tool.

statusbioassayed targetGALR1 length10 aa refs5
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 5 / 5
prediction metrics boltz-2 2.2.1
ipTM0.912
pTM0.911
avg pLDDT79.0
ranking score0.815
STRUCTURE · PEP-10335 × GALR1
ranking0.815
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 2.2.1 · mmCIF ↓ download
sequence10 aa
1510
WTLNSAGYLL
details expand to inspect
full evidence table1 metrics
metricvaluetool
Ki 870 nM GPCRDB/ChEMBL
3-letter notation
Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategycolabfold_local
runtime
predicted by
predicted at2026-05-22
citationbibtex
peptidemodel (2026). Lab peptide that targets brain galanin receptors (CHEMBL578710) (pep-10335, v1). PeptideModel. https://peptidemodel.com/card/pep-10335
@peptide{pep10335,
  sequence = {WTLNSAGYLL},
  target   = {galr1},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
clinical trials 0 trials · checked 2026-05-22
0
no registered clinical trials as of 2026-05-22; we'll re-check periodically
references 5 papers
[2]
Galanin receptors as a potential target for neurological disease
Freimann, K. et al. Expert Opinion on Therapeutic Targets 2015
evidence
[3]
Galanin Receptors and Ligands
Webling, K. et al. Frontiers in Endocrinology 2012
evidence
[4] supporting
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use